Come up with a name for your new list and we'll add to it:
GNA Biosolutions raised a round of funding on December 20, 2012. Investors include
Mey Capital Matrix.
GNA Biosolutions develops instruments, OEM modules, and assays for ultra-fast, molecular pathogen detection thanks to its breakthrough technology: Laser PCR, ultra-fast laser heating of nanoparticles,…